NORTHFIELD LABORATORIES INC /DE/·4

Dec 28, 12:14 PM ET

Visium Balanced Fund LP 4

4 · NORTHFIELD LABORATORIES INC /DE/ · Filed Dec 28, 2006

Insider Transaction Report

Form 4
Period: 2007-12-11
Transactions
  • Purchase

    Stock Option (right to buy)

    2006-12-14$1.32/sh+528$69727,337 total(indirect: See Footnotes)
    Exercise: $22.50From: 2006-12-08Exp: 2007-01-20Common Stock (52,800 underlying)
  • Sale

    Stock Option (right to buy)

    2006-12-12$3.59/sh4$1426,782 total(indirect: See Footnotes)
    Exercise: $17.50From: 2006-12-08Exp: 2007-02-17Common Stock (400 underlying)
  • Sale

    Stock Option (right to buy)

    2006-12-14$2.24/sh6$1327,337 total(indirect: See Footnotes)
    Exercise: $22.50From: 2006-12-08Exp: 2007-05-19Common Stock (600 underlying)
  • Sale

    Stock Option (right to buy)

    2006-12-11$2.44/sh10$2426,191 total(indirect: See Footnotes)
    Exercise: $22.50From: 2006-12-08Exp: 2007-05-19Common Stock (1,000 underlying)
  • Purchase

    Stock Option (right to buy)

    2006-12-15$8.53/sh+1,500$12,79525,150 total(indirect: See Footnotes)
    Exercise: $7.50From: 2006-12-08Exp: 2007-01-20Common Stock (150,000 underlying)
  • Expiration (Short)

    Stock Option (right to buy)

    2006-12-15$6.75/sh720$4,86025,150 total(indirect: See Footnotes)
    Exercise: $7.50From: 2006-12-08Exp: 2006-12-16Common Stock (72,000 underlying)
  • Sale

    Stock Option (right to buy)

    2006-12-11$3.39/sh51$17326,191 total(indirect: See Footnotes)
    Exercise: $17.50From: 2006-12-08Exp: 2007-02-17Common Stock (5,100 underlying)
  • Expiration (Short)

    Stock Option (right to buy)

    2006-12-15$5.18/sh400$2,07225,150 total(indirect: See Footnotes)
    Exercise: $10.00From: 2006-12-08Exp: 2006-12-16Common Stock (40,000 underlying)
  • Expiration (Short)

    Stock Option (right to buy)

    2006-12-1550025,150 total(indirect: See Footnotes)
    Exercise: $25.00From: 2006-12-08Exp: 2006-12-16Common Stock (50,000 underlying)
  • Sale

    Stock Option (right to buy)

    2006-12-15$2.84/sh1$325,150 total(indirect: See Footnotes)
    Exercise: $20.00From: 2006-12-08Exp: 2007-05-19Common Stock (100 underlying)
  • Purchase

    Stock Option (right to sell)

    2006-12-14$3.91/sh+250$97827,337 total(indirect: See Footnotes)
    Exercise: $15.00From: 2006-12-08Exp: 2007-01-20Common Stock (25,000 underlying)
  • Purchase

    Stock Option (right to sell)

    2006-12-13$0.53/sh+166$8826,809 total(indirect: See Footnotes)
    Exercise: $5.00From: 2006-12-08Exp: 2007-01-20Common Stock (16,600 underlying)
  • Sale

    Stock Option (right to buy)

    2006-12-14$3.39/sh1$327,337 total(indirect: See Footnotes)
    Exercise: $15.50From: 2006-12-08Exp: 2007-02-17Common Stock (100 underlying)
  • Sale

    Common Stock

    2006-12-15$14.96/sh293,000$4,383,2802,182 total(indirect: See Footnotes)
  • Purchase

    Stock Option (right to buy)

    2006-12-13$1.47/sh+27$4026,809 total(indirect: See Footnotes)
    Exercise: $22.50From: 2006-12-08Exp: 2007-01-20Common Stock (2,700 underlying)
  • Purchase

    Stock Option (right to buy)

    2006-12-15$0.85/sh1,650$1,40325,150 total(indirect: See Footnotes)
    Exercise: $25.00From: 2006-12-08Exp: 2007-01-20Common Stock (165,000 underlying)
  • Purchase

    Stock Option (right to sell)

    2006-12-15$0.06/sh+2,000$12025,150 total(indirect: See Footnotes)
    Exercise: $12.50From: 2006-12-08Exp: 2006-12-16Common Stock (200,000 underlying)
  • Purchase

    Common Stock

    2006-12-15$15.00/sh+107,500$1,612,5002,182 total(indirect: See Footnotes)
  • Sale

    Stock Option (right to sell)

    2006-12-15$3.87/sh3,000$11,61025,150 total(indirect: See Footnotes)
    Exercise: $15.00From: 2006-12-08Exp: 2007-01-20Common Stock (300,000 underlying)
  • Expiration (Short)

    Stock Option (right to buy)

    2006-12-151,81025,150 total(indirect: See Footnotes)
    Exercise: $20.00From: 2006-12-08Exp: 2006-12-16Common Stock (181,000 underlying)
  • Expiration (Short)

    Stock Option (right to buy)

    2006-12-154,80725,150 total(indirect: See Footnotes)
    Exercise: $22.50From: 2006-12-08Exp: 2006-12-16Common Stock (480,700 underlying)
  • Purchase

    Stock Option (right to buy)

    2006-12-15$2.67/sh+600$1,60225,150 total(indirect: See Footnotes)
    Exercise: $12.50From: 2006-12-08Exp: 2006-12-16Common Stock (60,000 underlying)
  • Purchase

    Stock Option (right to sell)

    2006-12-15$4.08/sh+3,046$12,42825,150 total(indirect: See Footnotes)
    Exercise: $15.00From: 2006-12-08Exp: 2007-01-20Common Stock (304,600 underlying)
  • Purchase

    Stock Option (right to buy)

    2006-12-15$1.28/sh+3,000$3,84025,150 total(indirect: See Footnotes)
    Exercise: $22.50From: 2006-12-08Exp: 2007-01-20Common Stock (300,000 underlying)
  • Expiration (Short)

    Stock Option (right to buy)

    2006-12-15$2.67/sh600$1,60225,150 total(indirect: See Footnotes)
    Exercise: $12.00From: 2006-12-08Exp: 2006-12-16Common Stock (60,000 underlying)
  • Purchase

    Stock Option (right to sell)

    2006-12-15$0.26/sh+1,775$46225,150 total(indirect: See Footnotes)
    Exercise: $15.00From: 2006-12-08Exp: 2006-12-16Common Stock (177,500 underlying)
Footnotes (2)
  • [F1]These shares are held as follows: Atlas Master Fund, Ltd. ("AMF") owns 5.86% or 157,788 shares; Visium Balanced Fund, LP ("VBF") owns 21.92% or 590,226 shares; Visium Long Bias Fund, LP ("VLB") owns 9.41% or 253,377 shares; Visium Balanced Offshore Fund, Ltd. ("VBOF") owns 36.34% or 978,505 shares; and Visium Long Bias Offshore Fund Ltd. ("VLBOF") owns 25.85% or 696,047 shares. Additionally, Dmitry Balyasny owns 0.63% or 16,695 shares. By virtue of its position as investment advisor and/or sub-advisor to each of Atlas Master Fund, Ltd. ("AMF"), Atlas Global, LLC ("AG"), Atlas Global Investments, Ltd. ("AGI"), Atlas Global Investments II, Ltd. ("AGII"), Visium Balanced Fund LP ("VBF"), Visium Long Bias Fund LP ("VLB"), Visium Balanced Offshore Fund, Ltd. ("VBOF") and Visium Long Bias Offshore Fund Ltd. ("VLBOF"), Balyasny Asset Management L.P. may be deemed to beneficially own all 2,692,639 shares of Common Stock.
  • [F2]By virtue of Atlas Global, LLC's ("AG") ownership of 10.79% of the equity interest in AMF, AG may be deemed to beneficially own the 157,788 shares of Northfield Laboratories, Inc.'s ("NFLD") stock that is beneficially owned by AMF. By virtue of Atlas Global Investments, Ltd. ("AGI") ownership of 83.72% of the equity interest in AMF, AGI may be deemed to beneficially own the 157,788 shares of NFLD stock that is beneficially owned by AMF. By virtue of Atlas Global Investments II, Ltd. ("AGII") ownership of 5.48% of the equity interest in AMF, AGII may be deemed to beneficially own the 157,788 shares of OTCI stock that is beneficially owned by AMF.

Documents

1 file
  • 4
    rrd140513.xmlPrimary

    FORM 4